Thistle Mary — SEC Form 4 filings
SEC reporting owner CIK 1317917. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-21.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-27 to 2026-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vigil Neuroscience, Inc. (VIGL) | Director | 4 | — | — | 13 |
| Q32 Bio Inc. (QTTB) | Director | 5 | — | — | 6 |
| Entrada Therapeutics, Inc. (TRDA) | Director | 3 | — | — | 3 |
| Cullinan Therapeutics, Inc. (CGEM) | Director | 2 | — | — | 2 |
Form 4 filings — Thistle Mary
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4/A | Q32 Bio Inc. (QTTB) | Grant/award (A): 10,826 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 25,319 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 9,810 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 53,521 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Vigil Neuroscience, Inc. (VIGL) | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 18,068 (derivative) · Disposition to issuer (D): 13,928 (derivative) · Disposition to issuer (D): 24,309 (derivative) · Disposition to issuer (D): 12,155 (derivative) | EDGAR |
| 2025-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Vigil Neuroscience, Inc. (VIGL) | Grant/award (A): 5,000 @ $0 | EDGAR |
| 2025-02-26 | 4 | Q32 Bio Inc. (QTTB) | Disposition to issuer (D): 12,767 (derivative) @ $0 · Grant/award (A): 12,767 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 25,743 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Vigil Neuroscience, Inc. (VIGL) | Grant/award (A): 18,068 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Vigil Neuroscience, Inc. (VIGL) | Disposition to issuer (D): 24,309 (derivative) @ $0 · Grant/award (A): 24,309 (derivative) @ $0 · Disposition to issuer (D): 12,155 (derivative) @ $0 · Grant/award (A): 12,155 (derivative) @ $0 · Disposition to issuer (D): 13,928 (derivative) @ $0 · Grant/award (A): 13,928 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 12,767 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1317917 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →